Try a new search

Format these results:

Searched for:

in-biosketch:true

person:mdk230

Total Results:

129


Pancreatic cancer surgery and nutrition management: a review of the current literature

Afaneh, Cheguevara; Gerszberg, Deborah; Slattery, Eoin; Seres, David S; Chabot, John A; Kluger, Michael D
Surgery remains the only curative treatment for pancreaticobiliary tumors. These patients typically present in a malnourished state. Various screening tools have been employed to help with preoperative risk stratification. Examples include the subjective global assessment (SGA), malnutrition universal screening tool (MUST), and nutritional risk index (NRI). Adequate studies have not been performed to determine if perioperative interventions, based on nutrition risk assessment, result in less morbidity and mortality. The routine use of gastric decompression with nasogastric sump tubes may be unnecessary following elective pancreatic resections. Instead, placement should be selective and employed on a case-by-case basis. A wide variety of feeding modalities are available, oral nutrition being the most effective. Artificial nutrition may be provided by temporary nasal tube (nasogastric, nasojejunal, or combined nasogastrojejunal tube) or surgically placed tube [gastrostomy (GT), jejunostomy (JT), gastrojejunostomy tubes (GJT)], and intravenously (parenteral nutrition, PN). The optimal tube for enteral feeding cannot be determined based on current data. Each is associated with a specific set of complications. Dual lumen tubes may be useful in the presence of delayed gastric emptying (DGE) as the stomach may be decompressed while feeds are delivered to the jejunum. However, all feeding tubes placed in the small intestine, except direct jejunostomies, commonly dislodge and retroflex into the stomach. Jejunostomies are associated with less frequent, but more serious complications. These include intestinal torsion and bowel necrosis. PN is associated with septic, metabolic, and access-related complications and should be the feeding strategy of last-resort. Enteral feeds are clearly preferred over parental nutrition. A sound understanding of perioperative nutrition may improve patient outcomes. Patients undergoing pancreatic cancer surgery should undergo multidisciplinary nutrition screening and intervention, and the surgical/oncological team should include nutrition professionals in managing these patients in the perioperative period.
PMCID:4318958
PMID: 25713805
ISSN: 2304-3881
CID: 5786342

A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis

Sugahara, Kazuki N; Scodeller, Pablo; Braun, Gary B; de Mendoza, Tatiana Hurtado; Yamazaki, Chisato M; Kluger, Michael D; Kitayama, Joji; Alvarez, Edwin; Howell, Stephen B; Teesalu, Tambet; Ruoslahti, Erkki; Lowy, Andrew M
Peritoneal carcinomatosis is a major source of morbidity and mortality in patients with advanced abdominal neoplasms. Intraperitoneal chemotherapy (IPC) is an area of intense interest given its efficacy in ovarian cancer. However, IPC suffers from poor drug penetration into peritoneal tumors. As such, extensive cytoreductive surgery is required prior to IPC. Here, we explore the utility of iRGD, a tumor-penetrating peptide, for improved tumor-specific penetration of intraperitoneal compounds and enhanced IPC in mice. Intraperitoneally administered iRGD significantly enhanced penetration of an attached fluorescein into disseminated peritoneal tumor nodules. The penetration was tumor-specific, circulation-independent, and mediated by the neuropilin-binding RXXK tissue-penetration peptide motif of iRGD. Q-iRGD, which fluoresces upon cleavage, including the one that leads to RXXK activation, specifically labeled peritoneal metastases displaying different growth patterns in mice. Importantly, iRGD enhanced intratumoral entry of intraperitoneally co-injected dextran to approximately 300% and doxorubicin to 250%. Intraperitoneal iRGD/doxorubicin combination therapy inhibited the growth of bulky peritoneal tumors and reduced systemic drug toxicity. iRGD delivered attached fluorescein and co-applied nanoparticles deep into fresh human peritoneal metastasis explants. These results indicate that intraperitoneal iRGD co-administration serves as a simple and effective strategy to facilitate tumor detection and improve the therapeutic index of IPC for peritoneal carcinomatosis.
PMCID:4508207
PMID: 26071630
ISSN: 1873-4995
CID: 5786352

PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions

Lee, Ser Yee; Kingham, T Peter; LaGratta, Maria D; Jessurun, Jose; Cherqui, Daniel; Jarnagin, William R; Kluger, Michael D
BACKGROUND:Hepatocellular adenoma (HCA) is the second most common benign liver neoplasm and occurs predominantly in women in their reproductive years. Positron-emission tomography (PET) using [18F] fluorodeoxyglucose (FDG) is commonly used in cancer staging, surveillance and evaluation of the treatment response. PET-avid HCA is rare and can be falsely interpreted as malignancies. METHODS:A retrospective review of four institutions' database was performed to identify the PET-avid HCAs with clinico-pathological correlation. RESULTS:Nine patients with histological proven PET-avid HCA was identified. Eight out of nine patients were female with a median age at diagnosis of 44 years. All patients' tumours with available histological subtyping (8/8) were HNF1-α mutated and had no inflammatory changes; six out the nine lesions had prominent (>50%) steatotic changes. CONCLUSION/CONCLUSIONS:Hepatocellular adenomas, specifically the HNF1-α subtype, can cause false-positive PET findings when seeking to identify malignancy. Concomitantly, PET-CT may have the potential to identify the HCA histopathological variant with the lowest malignant and haemorrhagic potential.
PMID: 26472264
ISSN: 1477-2574
CID: 5786362

Laparoscopic liver resection in patients with clinically significant cirrhosis: an Eastern perspective

Lee, Ser Yee; Kluger, Michael D
PMCID:4689689
PMID: 26734620
ISSN: 2304-3881
CID: 5786382

Professor Daniel Cherqui: my experiences with laparoscopic liver resection

Kluger, Michael D; Xu, Eunice X
PMCID:4689693
PMID: 26734628
ISSN: 2304-3881
CID: 5786392

Long-term outcomes of cytoreduction and HIPEC for malignant peritoneal mesothelioma [Meeting Abstract]

Bates, Gleneara Elizabeth; Kluger, Michael D; Jin, Zhezhen; Chabot, John A; Leinwand, Joshua; Bressler, Toby; Rae, Michelle; Taub, Robert N; Borczuk, Alain C; Hesdorffer, Mary
ISI:000358036900949
ISSN: 1527-7755
CID: 2121942

Techniques for safe organ recovery after endovascular aortic and bariatric operations [Letter]

Belin, Laurence J; Neely, Robert C; Kluger, Michael D
PMID: 24493164
ISSN: 1527-6473
CID: 5786312

Laparoscopic liver resection: basic skills for peripheral lesions

Kluger, Michael D
An evaluation of the literature demonstrates atypical wedge or single segment resections to be the most commonly performed laparoscopic liver procedures. Lesions that are both visible on the surface of segments 2-6 and ≤2-3 cm can be resected by most surgeons holding a fundamental understanding of liver anatomy. These criteria are based on the anatomical circumstance that sectoral and segmental pedicles should not course through depths necessary to obtain negative margins for these sized and positioned lesions. Videos of laparoscopic liver resections referenced in PubMed demonstrate complex procedures that are rarely performed and assume an advanced skill set for laparoscopic dissection and transection of parenchyma and management of vascular and biliary structures. Herein is demonstrated basic skill for peripheral resections via two cases in one video, so that these procedures can be safely performed by surgeons with commonly available laparoscopic equipment.
PMCID:3954992
PMID: 24696837
ISSN: 2304-3881
CID: 5786322

Single-center multidisciplinary management of patients with colorectal cancer and resectable synchronous liver metastases improves outcomes

Goyer, Perrine; Karoui, Mehdi; Vigano, Luca; Kluger, Michael; Luciani, Alain; Laurent, Alexis; Azoulay, Daniel; Cherqui, Daniel
BACKGROUND:Management of patients with synchronous liver metastasis (SLM) is complex and the surgical decision process should be based on a comprehensive oncological strategy. The aim of the study was to compare outcome of single-center management of patients with colorectal cancer (CRC) and resectable SLM to those of referred patients for liver resection only after removal of their primary tumor (PT). METHODS:Between 2000 and 2007, 47 patients with CRC and SLM underwent resection of both the PT and metastases under our care (unicentric) and 32 were referred after resection of their PT. RESULTS:The two groups were comparable for demographics, PT and metastatic disease data. In unicentric group, 23% received upfront chemotherapy with the PT in place, 53% had a combined CRC and SLM resection, 11% had a two-stage hepatectomy with resection of the primary during the first stage and 36% underwent delayed hepatectomy. The number of surgical interventions, the delay between diagnosis and liver resection (9 vs. 5 months, P < 0.001), the median number of cycles of chemotherapy before hepatectomy (12 vs. 6 months, P < 0.001) were significantly higher in the referred group. Postoperative morbidity was significantly higher in the referred group (75 vs. 47%, P = 0.023). The median follow-up was 43 months. OS and DFS were not significantly different between the two groups. CONCLUSION/CONCLUSIONS:Although the survival benefit is not proven, single-center management of patients with CRC and resectable SLM reduces the number of interventions, the number of cycles of chemotherapy and postoperative morbidity.
PMID: 22521121
ISSN: 2210-741x
CID: 5825842

Laparoscopic resection of hepatocellular carcinoma

Kluger, Michael D; Cherqui, Daniel
The current treatment of HCC is truly multidisciplinary. Notwithstanding, surgical management remains the gold standard which other therapies are compared to. Operative management is divided into transplantation and resection; the latter is further subdivided among open and laparoscopic approaches. Resection has become safer, remains superior to locoregional treatments, and can be a life-prolonging bridge to transplantation. The decision to pursue laparoscopic resection for HCC is driven by safety and a view toward the long-term management of both the malignancy and the underlying liver disease. For patients with a solitary HCC <5 cm in segments 2, 3, 4b, 5, and 6, no evidence of extrahepatic tumor burden, compensated liver disease, and the absence of significant portal hypertension, laparoscopy has an important role. Under these circumstances, resection can be performed with reduced mortality and morbidity and equivalent oncologic outcomes, disease-free survival, and overall survival when compared with similarly selected cirrhotic patients undergoing open resection. Blood loss and transfusion requirements are low, and laparoscopy itself does not expose the patient to complications and does not increase the risk of cancer recurrence or dissemination. Finally, because HCC recurrence remains high in the cirrhotic liver, treatment following surgical resection mandates routine surveillance and treatment by locoregional therapy, reresection, or transplantation as required-the latter two of which are facilitated by an initial laparoscopic resection.
PMID: 22941017
ISSN: 0080-0015
CID: 5786212